411 – 420 of 505
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Mild hypothermia reduces acute mortality and improves hemodynamic outcome in a cardiogenic shock pig model.
(
- Contribution to journal › Article
-
Mark
Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.
(
- Contribution to journal › Article
- 2009
-
Mark
Genetic variation of CYP2C19 affects both pharmacokinetic and pharmacodynamic responses to clopidogrel but not prasugrel in aspirin-treated patients with coronary artery disease
(
- Contribution to journal › Article
-
Mark
Assessment of P2Y(12) inhibition with the point-of-care device VerifyNow P2Y12 in patients treated with prasugrel or clopidogrel coadministered with aspirin
(
- Contribution to journal › Article
-
Mark
Mild Hypothermia Increases Adenosine Diphosphate-Stimulated Platelet Aggregation After Clopidogrel Administration in Healthy Volunteers
2009) 10th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology In Arteriosclerosis, Thrombosis and Vascular Biology 29(7). p.86-86(
- Contribution to journal › Published meeting abstract
-
Mark
Mild hypothermia does not attenuate platelet aggregation and may even increase ADP-stimulated platelet aggregation after clopidogrel treatment
(
- Contribution to journal › Article
- 2008
-
Mark
Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease
(
- Contribution to journal › Article
-
Mark
Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
(
- Contribution to journal › Article
-
Mark
ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors
(
- Contribution to journal › Published meeting abstract
-
Mark
P2-polymorphisms and cardiovascular disease
(
- Contribution to journal › Published meeting abstract